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Immunization through vaccination has been a commercially available pre-harvest
intervention to reduce E. coli shedding in cattle for about five years. Despite
demonstrated substantial improvement in human health that vaccine adoption
offers, it has not been widely adopted. This highlights the need for understanding the
economic situation underlying limited adoption. Using an equilibrium displacement
model, this study identifies the economic impact to U.S. feedlots implementing this
vaccination across a series of alternative scenarios. Producers face $1 billion to $1.8
billion in welfare losses over 10 years if they adopt this technology without any
associated increases in demand for fed cattle. Retail beef demand increases of 1.7%
to 3.0% or export demand increases of 18.1% to 32.6% would each individually make
producers economically neutral to adoption. Retail or packer cost decreases of 1.2%
to 3.9% would likewise be sufficient to make producers neutral to adoption.
Keywords: Adoption incentive; Beef; Cattle; Cost savings; Demand increases; E. coli O157;
Economic impacts; Food safety; Vaccination
Shiga toxin producing E. coli (STEC O157) is a serious human health hazard in the
United States. STEC-related bacteria cause more than 175,000 illnesses (Scallan et al.
2011) with an annual direct economic cost ranging from $489 million (USDA, ERS
2010) to $993 million (Scharff 2010). STEC O157 is naturally occurring in cattle and,
through presence in fecal material, threatens food safety if meat contamination occurs
during processing.
Because of the human health threat of E. coli, considerable beef industry and public
health official efforts have targeted pathogen reduction in beef processing plants
including development of extensive hazard analysis critical control points (HACCP)
and intensive testing of beef for E. coli presence (Ferrier and Buzby 2013). Pre-harvest
interventions to reduce pathogens in live cattle have arisen as one strategy to lessen
chances of post-harvest bacterial contamination of beef. If pathogen presence can be
reduced prior to slaughter, the probability of meat contamination during carcass
processing will likewise decline (Dodd et al. 2011; Hurd and Malladi 2012).
Vaccines can reduce shedding of E. coli in ruminants (Snedeker et al. 2012; Varela
et al. 2013; Vogstad et al. 2013). A recently developed commercially available pre-harvest
intervention to reduce E. coli shedding in cattle is immunization through vaccination
(Cull et al. 2012). Despite recognition of the potential reduction in foodborne illness that
could result from use of cattle E. coli vaccination, adoption is very limited (Callaway et al.2015 Tonsor and Schroeder; licensee Springer. This is an Open Access article distributed under the terms of the Creative Commons
ttribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any
edium, provided the original work is properly credited.
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associated with E. coli O157:H7 prevalence as cattle feeding efficiency is not hindered.
Furthermore, a well-established market that compensates producers for vaccinating for
STEC 0157 has not developed. Thus, an externality exists because feedlots will not imple-
ment the socially optimal level of intervention without directly visible economic incen-
tives. Doing so adds costs without directly visible offsetting increases in revenue. The fact
that producers do not have direct incentives to employ E. coli vaccination, even though
doing so would increase beef food safety, led a recent USA Today article to claim “the
economics are backwards” (Weise 2011).
Despite the obvious importance to food safety and human foodborne illness, the
economic feasibility and impacts of producer adoption of cattle immunization
against E. coli have not been determined. The purpose of this study is to evaluate the
economic impacts of incorporating animal vaccination into E. coli pre-harvest con-
trol practices. Specifically this study estimates direct producer costs associated with
use of a vaccine in cattle feeding, referred to here as an E. coli vaccine. Direct costs
include vaccine cost, costs of administering, and potential animal feeding performance
impacts associated with the vaccination. Potential benefits include reduced packer or
retailer costs associated with lower risk of pathogens, reduced food safety concerns, and
potentially increased domestic consumer or export demand associated with safer beef. To
estimate market level impacts of the vaccination, we use an equilibrium displacement
model (EDM) that incorporates supply and demand shifts associated with the cattle
immunization to determine economic impacts of the food safety technology across a
series of alternative scenarios.
Estimating economic impacts of E. coli vaccines being adopted by feedlot operators is
important for several reasons. First, feedlot operators need additional information to
make sound adoption decisions. Secondly, understanding broader market impacts of
possible adoption highlights how net benefits are distributed throughout the industry.
Third, society’s ongoing interest in food safety and associated desire for regular im-
provements in risk mitigation protocols further motivates interest from those outside
the beef production chain. Given the apparent market failure of E. coli vaccination
adoption, an assessment of economic impacts and sensitivity to various market reac-
tions has important policy implications.
Background
Vaccination against E. coli O157:H7 and fecal shedding has been available in the United
States for over five years with the first licensed vaccine approved in February 2009. The
vaccine is a siderophore receptor and porin (SRP®) protein exclusively marketed by
Zoetisa. The vaccine is administered to feedlot cattle during the feeding phase of
production with two or three dosesb.
A couple of particularly noteworthy studies have examined the effectiveness of the
vaccine in reducing fed cattle fecal concentrations of E. coli O157:H7 and in its impact
on cattle feeding performance. Thomson et al. (2009) found use of the SRP® vaccine
reduced fecal shedding concentrations in fed cattle by up to 98% and cattle feeding
performance was unaffected. Cull et al. (2012) found that two doses of SRP® reduced
shedding by more than 50% and reduced high shedders by more than 75%. However,
Cull et al. (2012) identified a small, but statistically and economically important,
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average daily gain declined by 2.7% and feed conversion increased by 2.1% for vaccinated
relative to unvaccinated cattle. The reduction in animal performance was hypothesized to
be associated with the second vaccination where the vaccinated animals were processed
in a chute an additional time relative to the control non-vaccinated cattle. In Thomson
et al. (2009) the control cattle were vaccinated with a placebo each time, so the numbers
of chute processes were the same for the control and E. coli vaccinated cattle. Running
cattle through a chute can result in cattle shrink that may not be fully recaptured when
placed back on feed and can temporarily disrupt cattle feed intake (Blasi et al. 2009).
Given the differences in experimental results relative to cattle feeding performance
impacts associated with administration of an E. coli vaccine, we allow for alternative
assumptions in our economic analyses. In particular, we consider two alternatives, one
assuming no reduction in animal performance and a second assuming a 2.7% reduction
in average daily gain and a 2.1% increase in feed conversion (pounds of feed per pound
of gain) as a result of the vaccination.
Important to also consider are possible demand improvements or cost savings that
could potentially follow implementation of E. coli vaccine programs at the feedlot level.
Moghadam et al. (2013) estimate that E. coli O157:H7 recalls by the USDA Food Safety
Inspection Service (FSIS) have a rapid and important economic impact on live cattle
futures markets amounting to approximately $6/head for all cattle slaughtered in the
United States. Domestic beef demand has been harmed by past FSIS recall events
(Marsh et al. 2004; Piggott and Marsh 2004; Tonsor et al. 2010). Furthermore, export
market demand for U.S. beef is highly sensitive to food safety (Bailey 2007). As such,
domestic retail beef demand and wholesale export beef demand could improve with E.
coli vaccine programs that reduce E. coli prevalence.
Extensive research has examined the cost impacts of additional food safety programs
and protocols being introduced into the U.S. beef industry (Antle 1999; 2000). Costs
include direct production costs such as additional labor requirements, slowing down
processing line speed, investing in food safety technologies, modifying processing pro-
cedures or facilities, and expenses of more intensive product sampling and food safety
testing (Ferrier and Buzby 2013). In face of a recall, costs of plant down-time, clean up,
physical product losses, costs of completing a food recall, and loss of firm customers
and reputation can collectively be substantial. Important expenses also include possible
litigation costs associated with foodborne human illnesses that have proved expensive in
cases where meat food safety breaches have occurred (e.g., Gabbett 2010; Scott 2012).
Given the sizeable costs involved to downstream firms in light of a food safety event,
substantial incentives are present to reduce the probabilities of such events including
the possibility of feedlots implementing E. coli vaccine programs. In essence, use of an
E. coli vaccine by cattle producers could result in notable benefits to downstream firms
but direct benefits to producers that incur the costs of adoption are currently elusive,
limiting adoption.
Given the economic importance of identifying the economic impact E. coli vaccine
program introduction could have on stakeholders throughout the meat and livestock
chain we first directly estimate market impacts in the absence of incentivizing demand
improvements or possible downstream cost savings. Given the unknown nature of
possible demand or cost improvements we then proceed to estimate market impacts
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or cost savings that would be needed to make feedlot operators in aggregate indifferent
to adoption.
Estimating and discussing these demand or cost improvements that may lead to feedlot
adoption is important for several reasons. First, as the levels of demand or cost adjust-
ments that could be experienced elsewhere in the supply chain are realized, having critical
thresholds identified is valuable. Second, cattle producers would adopt vaccine programs
if they received offsetting benefits which reinforces the value in identifying necessary de-
mand or cost improvements further upstream to encourage adoption (Smith et al. 2013).
Finally, from a policy perspective, any cost-benefit analysis of alternative beef food safety
enhancing interventions requires the information provided in this study regarding market
impacts of these interventions.
Methods
The methodological approach can succinctly be described as using estimates of costs
increases incurred by feedlots implementing E. coli vaccination programs and estimating
changes in prices and quantities at market levels spanning the vertically linked beef indus-
try as well as connected pork and poultry markets. The initial exogenous market shock is
feedlot level production costs increasing leading to an inward shift in fed cattle supply. To
estimate the market level impact of E. coli vaccination on prices and quantities through-
out the livestock and meat industry we employ an equilibrium displacement model
(EDM). The EDM utilized here is similar to that used by Schroeder and Tonsor (2011)
and is documented in the appendix.
The EDM is composed of four sectors in the beef industry: 1) retail (consumer), 2)
wholesale (processor/packer), 3) fed cattle (cattle feeding in feedlots), and 4) farm
(feeder cattle from cow-calf producers). To capture interactions between retail meat
substitutes for beef we also include the pork and poultry markets. Reflecting the higher
degree of integration relative to the beef industry, the economic model includes three
pork marketing chain sectors (retail, wholesale, and fed cattle) and the poultry marketing
chain is composed of two sectors (retail and wholesale). International trade is explicitly
incorporated in the model at the wholesale level for all three species. The resulting
framework is consistent with existing research and follows the recent work of Brester
et al. (2004) and Pendell et al. (2010).
Given estimated changes in prices and quantities, producer surplus at the feedlot
level where the adoption decision occurs, as well as other levels in the vertically linked
supply chain, is calculated as a widely accepted measure of economic welfare impact.
As in most EDM applications, direct estimation of elasticities is prohibitive because of
the large number of equations and identification problems in jointly estimating supply
and demand relationships (Brester et al. 2004). However, given the E. coli vaccination
results in relatively small aggregate market shifts (in proportional terms), we follow
standard EDM procedures and utilize elasticity estimates reported in the published
literature to parameterize the model.
We simulate our model annually for ten consecutive years to trace a hypothetical
adoption path over time by producers of the E. coli vaccination technology. Consistent
with historical beef cattle cycles, we assume it takes the marketplace ten years to fully
adjust from short-run to long-run relationships. Ten years of market effects were
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(year 10) using elasticity estimates employed by Pendell et al. (2010)c. Supply, demand,
and quantity transmission elasticities used are equivalent to those used by Schroeder
and Tonsor (2011). Similarly, base price and quantity values are necessary to estimate
surplus calculations. The market price and quantity values are annual averages for
calendar year 2012 as reported by the Livestock Marketing Information Center (LMIC).
Our analysis assumes 10% of fed cattle are vaccinated in year 1, 25% in year 2, 50% in
year 3, and 90% in years 4–10. This reflects a typical “S-curve” adoption pattern where
adoption increases rapidly upon introduction of the technology with a plateau corre-
sponding to the fact that few technologies are ever completely adopted by all parties in
a heterogeneous industry. The employed adoption rate would of course only occur if
private market incentives to adopt were widely present and accessible to producers,
which currently they are not. As such, the adoption rate is used here for exemplifica-
tion and estimation of cost impacts and is not a forecast of a probable adoption path
given current market conditions.
Results
When feedlot operators implement E. coli vaccination protocols one main direct impact
serves as the initial shock in our EDM. Specifically, production costs increase leading to
an inward shift in fed cattle supply. This initial exogenous shock initiates a ripple-effect
through the industry as reflected in multiple endogenous shifts outlined within the EDM.
The change in net returns of finishing cattle for those implementing E. coli vacci-
nations were calculated under alternative assumptions following Lueger et al. (2012).
When assuming no animal performance impact, the direct costs are estimated at
$6.47/head with the vaccination being administered twice to each animal. The first
vaccination occurs upon arrival at the feedlot where cattle are all processed through
a chute anyway (so no additional chute charge or animal processing is associated
uniquely to the E. coli vaccination). For the second vaccination, additional chute and
labor charges occur since cattle would not generally be processed through the chute
again unless being vaccinated for E. coli. One potentially important addition to the
direct costs of vaccinating is whether an adverse animal performance outcome
occurs from the vaccination. Research includes no impact (Thomson et al. 2009) to
an observed animal performance decline (Cull et al. 2012). As such, a second cost
scenario is assumed where the direct costs that include vaccination and animal
performance losses are estimated at $13.11/head (Lueger et al. 2012). In addition to
these base direct costs, adopting feedyards could incur costs associated with third-party
verification that E. coli vaccinations were indeed implemented if packers were going to
pay them for such a verified production protocol. We assume E. coli vaccination verifica-
tion costs of $1.88/head which are based on costs for age and source verification identified
by Pendell et al. (2013).
Given the magnitude of the direct costs for feedlots to vaccinate, they generally will
not without a clear direct economic incentive. As such, determining the downstream
benefits that would need to occur to encourage adoption is essential to understand if
adoption is desirable. The $/head implementation costs are presented in Table 1 along
with the exogenous supply shifts these cost increases represent in each year within the
EDM given an average fed cattle value in 2012 of $1,604/head.
Table 1 Exogenous fed cattle production cost increase of vaccination and verification
program adoption
Percentage inward supply shift
Scenario: Direct
Cost
Year 1 Year 2 Year 3 Years 4-10
10% 25% 50% 90%
$/hda Adoption Adoption Adoption Adoption
No animal performance impact $8.35 0.052% 0.130% 0.260% 0.468%
Animal performance impact $14.99 0.093% 0.234% 0.467% 0.841%
aIncludes $6.47 per head cost of vaccinating plus $1.88 per head verification cost under no animal performance impact
and $13.11 per head cost under performance impact plus $1.88 per head verification cost.
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ation program implementation without additional demand or cost benefits occurring else-
where in the supply chain. This scenario of course would not happen because feedlots will
not adopt without clear direct benefits. But having this scenario is necessary to determine
the subsequent magnitudes of market events that would need to occur to entice adoption.
Table 2 summarizes the short- (1-year), intermediate- (5-year), and long-run (10-year)
changes in prices and quantities estimated by the EDM where animal performance
impacts are omitted and considered. Retail and wholesale beef as well as fed cattle, and
feeder cattle quantities all decline in each of the 10 years considered. The reduced pro-
duction volumes reflect the inward shift in fed cattle supply, derived inward shifts in
wholesale and retail beef supplies, and derived demand reductions experienced at the
feeder cattle level following the increased production costs for feedlots. Retail and
wholesale beef prices increase in all 10 years as the increased feedlot costs pass verti-
cally towards consumers. Feeder cattle prices decline in all 10 years as feedlot vaccin-
ation costs reduce derived demand for feeder cattle. The fed cattle price path switches
signs over the 10 years examined. Specifically, fed cattle prices decline in years 1 and 2
and increase over years 3–10 reflecting long-run supply being more elastic than short-
run supply and a multitude of derived demand and supply feedbacks captured by the
model. The quantities of wholesale beef exported and imported, as well as the price of
imported wholesale beef all decline over the 10 years evaluated. This primarily follows
an overall reduction in wholesale beef supplies and increased wholesale beef prices.
More broadly, the long-run impacts are smaller as the entire supply chain adjusts to
E. coli vaccination program implementation over time.
In the base situation of no additional demand enhancement or cost savings, the
cumulative net present value producer surplus losses over ten years at the feedlot
level are $1.00 billion if no animal performance reduction occurred by vaccinating
and $1.79 billion if reduced animal performance is considered (Table 3). This substantial
difference in welfare, despite small potential impacts on animal performance, clearly illus-
trates how the economic value of interventions changes if animal productivity is affected.
These substantial losses reflect changes in prices and quantities summarized in
Table 2 and occur if the adoption rate we assume and no offsetting benefits materialize.
This illustrates why, consistent with Matthews et al. (2013) and Callaway et al. (2013),
limited voluntary adoption of E. coli vaccination will occur unless recognized direct
incentives for implementation arise. Such incentives could occur in the form of derived
demand increasing for fed cattle from feedlots with E. coli vaccination programs if
either domestic retail or wholesale export beef demand increased following program
Table 2 Percentage change in endogenous variables of the equilibrium displacement
models with adoption costs but no benefits scenario
No animal performance impact With animal performance impact
Endogenous variables Short run Intermediate Long run Short run Intermediate Long run
Retail beef quantity −0.27% −0.04% −0.01%’ −0.49% −0.06% −0.01%
Retail beef price 0.32% 0.04% 0.01% 0.58% 0.06% 0.01%
Wholesale beef quantity −0.51% −0.15% −0.04% −0.91% −0.27% −0.07%
Wholesale beef price 0.40% 0.16% 0.04% 0.72% 0.28% 0.07%
Slaughter cattle quantity −0.40% −0.28% −0.12% −0.72% −0.51% −0.21%
Slaughter cattle price −0.38% 0.26% 0.14% −0.68% 0.46% 0.25%
Feeder cattle quantity −0.23% −0.21% −0.09% −0.42% −0.37% −0.16%
Feeder cattle price −1.06% −0.15% −0.03% −1.91% −0.27% −0.06%
Imported wholesale beef quantity −0.38% −0.13% −0.04% −0.69% −0.24% −0.07%
Exported wholesale beef quantity −0.17% −0.24% −0.11% −0.30% −0.44% −0.20%
Imported wholesale beef price −0.21% −0.02% 0.00% −0.37% −0.04% −0.01%
Retail pork quantity 0.04% 0.01% 0.00% 0.08% 0.01% 0.00%
Retail pork price 0.02% 0.00% 0.00% 0.04% 0.00% 0.00%
Wholesale pork quantity 0.03% 0.01% 0.00% 0.05% 0.01% 0.00%
Wholesale pork price 0.02% 0.00% 0.00% 0.03% 0.00% 0.00%
Slaughter hogs quantity 0.01% 0.00% 0.00% 0.02% 0.01% 0.00%
Slaughter hogs price 0.03% 0.00% 0.00% 0.06% 0.01% 0.00%
Imported wholesale pork quantity 0.02% 0.00% 0.00% 0.03% 0.01% 0.00%
Exported wholesale pork quantity −0.02% 0.00% 0.00% −0.03% 0.00% 0.00%
Imported wholesale pork price 0.01% 0.00% 0.00% 0.02% 0.00% 0.00%
Retail poultry quantity 0.05% 0.01% 0.00% 0.08% 0.01% 0.00%
Retail poultry price 0.04% 0.00% 0.00% 0.08% 0.00% 0.00%
Wholesale poultry quantity 0.05% 0.01% 0.00% 0.09% 0.01% 0.00%
Wholesale poultry price 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Exported wholesale poultry quantity −0.32% −0.04% −0.01% −0.57% −0.08% −0.01%
Note: These percentage changes are relative to 0% vaccination and verification adoption. Short-, intermediate-, and long-run
corresponds to years 1, 5, and 10, respectively from the EDM simulated over 10 consecutive years. Percentage changes for
each individual year are available upon request.
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costs at either the retail or wholesale level declined following E. coli vaccination
program implementation. Given these unknown but important plausible alternatives,
we extended our analysis and utilized the EDM to identify demand benefits or cost
savings needed to make the feedlot level indifferent to adoption.
Table 4 presents the estimated retail demand increase, wholesale export demand
increase, retail cost savings, and wholesale costs savings that result in no changes in
producer surplus at the fed cattle (feedlot) leveld. Note, the estimates in Table 4 are
for independent downstream shocks to demand or costs needed to make feedlot
producers economically indifferent to adoption. Possible combinations of demand
and cost impacts would be smaller than individual shocks necessary to make feedlot
producers indifferent. The minimum changes that may lead to feedlot adoption are
lower in each case where implementing an E. coli vaccination program does not
impact animal performance.
Table 3 Producer surplus changes from vaccination and verification program adoption ($ millions), no benefits scenario
No animal performance impact With animal performance impact
Beef producer surplus Short run Intermediate run Long run Cumulative present value Short run Intermediate run Long run Cumulative present value
Retail level 294.05 32.58 5.07 654.66 527.41 58.49 9.10 1,174.59
Wholesale level 197.81 76.67 18.49 804.03 354.46 137.58 33.20 1,441.69
Fed cattle level −224.72 −110.56 −173.92 −1,000.90 −402.86 −198.29 −312.13 −1,795.23
Feeder cattle level −434.83 −61.77 −12.98 −1,018.27 −780.04 −110.82 −23.30 −1,826.42
Total Beef Industry Producer Surplus −167.69 −63.08 −163.33 −560.48 −301.02 −113.04 −293.13 −1,005.37



















Domestic retail beef demand increase 1.7% 3.0%
Wholesale export beef demand increase 18.1% 32.6%
Retail beef (retailer) cost decrease 2.2% 3.9%
Wholesale beef (packer) cost decrease 1.2% 2.2%
Note: Values are the exogenous responses (demand increases or cost savings) resulting in cumulative net present value
of producer surplus not changing at the fed cattle level (feedlots). Demand increases on all beef production were
considered while cost savings evaluated corresponded only to the portion of product retailers or packers would receive
from E. coli vaccination programs reflecting the 10-year adoption path assumed.
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retail beef demand or a 32.6% increase in wholesale export beef demand would provide
the derived demand benefits to make feedlot operators indifferent to implementation.
The 3.0% domestic retail demand increase is within the range of experienced annual
demand shifts in the U.S. (AgManager 2013). However, the finding of Zingg and Siegrist
(2012) that a minority of consumers may be willing to consume meat from vaccinated
animals casts some doubt on the extent of a positive, aggregate retail demand response.
In 2012 Japan and South Korea combined accounted for 30.8% of total U.S. beef exports
(LMIC 2013). Accordingly, context on the 32.6% wholesale export increase can readily be
made noting how maintaining access to Japan and South Korea by avoiding food-safety
related market closures could offset feedlot level vaccination program costs. The iden-
tification of thresholds for export demand increases being approximately 10 times
those of domestic demand increases reflects the fact approximately 90% of beef produced
in the U.S. is consumed domestically. While domestic and export demand responses are
unknown, recognizing the demand response thresholds is important for broader industry-
wide deliberations and sets the stage for additional future research.
Table 4 also indicates that 3.9% (2.2%) cost savings for retailers or 2.2% (1.2%) cost
savings for packers results in no net economic welfare changes for the feedlot segment
if animal productivity is (not) reduced through a vaccination protocol. As with the
threshold demand values, the precise level of cost savings at retail or wholesale levels
are unknown as adjustments that operations may make in E. coli mitigation efforts have
yet to be directly studied. Hurd and Malladi (2012) concluded that the number of
ground beef-related E. coli human illnesses in the United States could be reduced by
58% from about 20,000 illnesses to around 8,400 per year under an 80% effective and
fully adopted feedlot steer and heifer vaccination program. Smith et al. (2013) found
combinations of interventions applied pre-harvest and throughout processing resulted
in larger relative E. coli risk reductions. If a single and relatively simple intervention
such as a vaccination program would have this dramatic of impact on foodborne illnesses,
downstream cost savings would certainly be realized. Estimating potential downstream
cost savings is an area ripe for future research.
Discussion and Conclusions
This study expands knowledge of economic implications of implementing E. coli
vaccination programs, highlights key areas of where additional research would be
valuable, and provides information that could improve societal response to efficiently
mitigating food safety risks. Vaccinations by feedlots could potentially reduce E. coli
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2012). However, cattle producers will not adopt E. coli vaccination programs without
offsetting direct benefits because doing so is costly and would reduce their economic
welfare by $1 billion to $1.8 billion. Currently, direct benefits of E. coli vaccine adop-
tion by cattle producers are elusive as a well-established market premium does not
exist despite the vaccine having been commercially available for over five years now.
What might it take for E. coli vaccination programs to be successfully implemented?
We illustrate the threshold magnitudes of downstream demand improvements or cost
savings that are needed to provide producers economic incentives to adopt E. coli vaccin-
ation programs. Domestic consumer demand increases of 2-3%, export wholesale market
increases of 18-33%, retailer cost reductions of 2-4%, or processor cost reductions of 1-2%
would each individually be sufficient to make producer adoption welfare neutral.
This study also highlights the need to further examine if human health benefits from
implementing E. coli vaccination programs are significant enough to consider additional
policy adjustments that encourage adoption. This issue is beyond the economics of
adoption focused scope of this paper but certainly is an area of importance for future
research. Similarly, a valuable area for future research is to consider the demand
increase and cost reduction thresholds identified in this study and determine
whether and how E. coli vaccination adoption incentives might occur and translate
incentives back to cattle producers.
Endnotes
aSee: https://online.zoetis.com/US/EN/Solutions/Pages/SRPEcoli/index.aspx
bExperiments with both two doses and three doses have been conducted (Cull et al.
2012; Thomson et al. 2009) with three doses showing a trend in efficacy.
cAvailable at: http://ajae.oxfordjournals.org/content/suppl/2010/04/29/aaq037.DC1/
aaq037supp.pdf
dDemand increases were modelled to impact 100% of production over the 10 year
period while cost increases were modelled to impact only the portion of production
that aligns with feedlot vaccination adoption. That is, demand increases reflect an as-
sumption of product being undifferentiated downstream to buyers while cost increases
reflect an assumption of downstream purchases only experiencing cost savings when
product is verified to be sourced from adopting feedyards.
eThis model follows Pendell et al. (2010) and similar studies in assuming international
trade can be succinctly captured by including exchange of meat products while not
explicitly incorporating live animal trade.
fAvailable at: http://ajae.oxfordjournals.org/content/suppl/2010/04/29/aaq037.DC1/
aaq037supp.pdf
APPENDIX - Details of Applied Equilibrium Displacement Model
To estimate the market level impact of E. coli vaccination we employ an equilibrium
displacement model (EDM). The EDM utilized here is similar to that used by Schroeder
and Tonsor (2011). The EDM is composed of four sectors in the beef industry: 1) retail
(consumer), 2) wholesale (processor/packer), 3) fed cattle (cattle feeding in feedlots), and
4) farm (feeder cattle from cow-calf producers). To capture interactions between retail
meat substitutes for beef we also include the pork and poultry markets. Reflecting the
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three pork marketing chain sectors (retail, wholesale, and fed cattle) and the poultry
marketing chain is composed of two sectors (retail and wholesale). International trade
is explicitly incorporated in the model at the wholesale level for all three species. The
resulting framework is consistent with existing research and most closely follows the
recent work of Brester et al. (2004) and Pendell et al. (2010). The structural model
(omitting error terms for convenience) is given by the following series of general
demand and supply equations of this multi-species model. Superscripts r, w, s, and f
denote the retail, wholesale, fed cattle, and farm market levels, respectively; subscripts
B, K, and Y denote beef, pork, and poultry, respectively; P is price; Q is quantity; and Z
and W denote demand and supply shifters, respectively. Consistent with existing inter-
national trade, the model captures imports (subscript i) and exports (subscript e) of
beef, pork, and poultrye. Equations (1) - (25) omit superscripts for demand and supply
as market clearing conditions are imposed, requiring demand and supply to equal.
Beef marketing chain
(1)Retail beef primary demand: QrB ¼ f 1 PrB; PrK ; PrY ;ZrB
 
;
(2)Retail beef derived supply: QrB ¼ f 2 PrB;QwB ;WrB
 
;
(3)Wholesale beef derived demand: QwB ¼ f 3 PwB ;QrB;ZwB
 
;
(4)Wholesale beef derived supply: QwB ¼ f 4 PwB ;QsB;QwBi;QwBe;WwB
 
;
(5)Imported wholesale beef derived demand: QwBi ¼ f 5 PwBi;QwB ;ZwBi
 
;
(6)Imported wholesale beef derived supply: QwBi ¼ f 6 PwBi;WwBi
 
;
(7)Exported wholesale beef derived demand: QwBe ¼ f 7 PwB ;ZwBe
 
;
(8)Fed cattle derived demand: QsB ¼ f 8 PsB;QwB ;ZsB
 
;
(9)Fed cattle derived supply: QsB ¼ f 9 PsB;QfB;WsB
 
;
(10)Farm (feeder cattle) derived demand: QfB ¼ f 10 PfB;QsB;ZfB
 
;




(12)Retail pork primary demand: QrK ¼ f 12 PrB; PrK ; PrY ;ZrK
 
;
(13)Retail pork derived supply: QrK ¼ f 13 PrK ;QwK ;WrK
 
;
(14)Wholesale pork derived demand: QwK ¼ f 14 PwK ;QrK ;ZwK
 
;
(15)Wholesale pork derived supply: QwK ¼ f 15 PwK ;QsK ;QwKi;QwKe;WwB
 
;
(16)Imported wholesale pork derived demand: QwKi ¼ f 16 PwKi;QwK ;ZwKi
 
;
(17)Imported wholesale pork derived supply: QwKi ¼ f 17 PwKi;WwKi
 
;
(18)Exported wholesale pork derived demand: QwKe ¼ f 18 PwK ;ZwKe
 
;
(19)Market hog derived demand: QsK ¼ f 19 PsK ;QwK ;ZsK
 
;




(21)Retail poultry primary demand: QrY ¼ f 21 PrB; PrK ; PrY ;ZrY
 
;
(22)Retail poultry derived supply: QrY ¼ f 22 PrY ;QwY ;QrYe;WrY
 
;
(23)Wholesale poultry derived demand: QwY ¼ f 23 PwY ;QrY ;ZwY
 
;
Tonsor and Schroeder Agricultural and Food Economics  (2015) 3:7 Page 12 of 15(24)Wholesale poultry primary supply: QwY ¼ f 24 PwY ;WwY
 
;
(25)Exported wholesale poultry derived demand: QwYe ¼ f 25 PwY ;ZwYe
 
:
Consistent with Wohlgenant (1993), we incorporate variable input proportions by
allowing production quantities to vary across the market levels in the marketing chain.
Totally differentiating equations (1) - (25), including variable input proportions, and
placing all the endogenous variables on the left-hand side of each equation and isolating
exogenous effects to the right-hand side of each equation results in the following EDM. E
represents a relative change operator (i.e., EQ = d lnQ = dQ/Q); ηma is the own-price elasti-
city of meat/species a demand at market level m; ηmab is the cross-price elasticity of
demand for meat a with respect to retail prices of meat b; εma is the own-price elasticity of
meat/species a supply at market level m; τlm is the percentage change in quantity
demanded at market level m given a 1% change in quantity demanded at market level l;
γlm is the percentage change in quantity supplied at market level m given a 1% change in
quantity supplied at market level l. In this specification, market levels are linked by down-
stream quantity variables among the demand equations and upstream quantity variables
among the supply equations (Wohlgenant 1993).
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EQwBe ¼ EWwB ;
(5″) Imported wholesale beef derived demand: EQw − ηw EPw − τrwEQw ¼ Qw =Qw Bi Bi Bi B B Bi B
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K ¼ EWsK ;
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Balagtas and Kim (2007) note this model can be expressed in matrix form as RY = Z,
where R is a matrix of model parameters (i.e., elasticities), Y is a column vector of
endogenous changes in prices and quantities relative to an initial equilibrium, and Z is
a column vector of percentage changes associated with vaccination protocol adoption.
The model defines proportional changes in equilibrium prices and quantities for each
evaluated market level and species in response to exogenous changes corresponding to
vaccination introduction. These proportional changes are identified as:
26ð Þ Y ¼ R−1Z:
We use producer surplus to quantify the net economic impact of vaccination adoption.
Changes in producer surplus created by introducing vaccinations can be calculated in
terms of changes in prices and quantities identified by the EDM as:





where producer surplus is denoted by PS (Lusk and Anderson 2004). The superscript m
denotes the market level (i.e., r = retail, w =wholesale (processor/packer), s = fed cattle
(feeding), and f = feeder (farm level)) and subscript a denotes the industry/species evalu-
ated (i.e., beef, pork, or poultry). Change in total producer surplus is the sum of the




Solutions to equation (26) require elasticity estimates for the matrix of parameters
(R). Identifying these estimates by econometrically estimating structural supply and
demand equations for the 25-equation EDM is problematic. As in most EDM applica-
tions, direct estimation of elasticities is prohibited by the large number of equations
and by identification problems in jointly estimating supply and demand relationships
(Brester et al. 2004). However, given the E. coli vaccination results in relatively small
aggregate market shifts (in proportional terms), we follow standard EDM procedures
and utilize elasticity estimates reported in the published literature.
We simulate our model annually for ten consecutive years to allow for adoption over
time by producers of the E. coli vaccination technology. Consistent with historical beef
cattle cycles, we assume that it takes the marketplace ten years to fully adjust from
short-run to long-run relationships. Ten years of market effects were simulated by
linearly adjusting all elasticities between short-run (year 1) and long-run (year 10) using
elasticity estimates employed by Pendell et al. (2010)f. The supply, demand, and quan-
tity transmission elasticities used are equivalent to those used by Schroeder and Tonsor
(2011). Similarly, base price and quantity values are necessary to estimate surplus
Tonsor and Schroeder Agricultural and Food Economics  (2015) 3:7 Page 14 of 15calculations. The market price and quantity values are annual average values for
calendar year 2012 as reported by the Livestock Marketing Information Center (LMIC).
Our analysis assumes 10% of fed cattle are vaccinated in year 1, 25% in year 2, 50% in
year 3, and 90% in years 4–10. This reflects a typical “S-curve” adoption pattern where
adoption increases rapidly upon introduction of the technology with a plateau corre-
sponding to the fact that few technologies are every completely adopted by all parties
in a heterogeneous industry.
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